Worldwide many patients suffer from an allergy towards different pharmaceutical drugs such as penicillin. However, the precise diagnosis still remains a daunting task. We offer an attractive solution for drug allergy verification.
Integrated photonic biosensing structures demonstrated their huge potential in the last decades. Our sensor provides significant advantages compared to other existing technologies.
Our diverse team helps to understand and provide unique solutions to the medical diagnosis of drug allergy detection.
This company is capitalized by Innvierte, an investmentprogram of CDTI, E.P.E.
IMPACT-Photonics "Subvencionado por el CDTI" y "Financiado por la Unión Europea - NextGenerationEU"
Proyecto CPP2022-009994 financiado por MICIU/AEI /10.13039/501100011033 y por la Unión Europea NextGenerationEU/ PRTR